Abstract:BACKGROUND:Nonalcoholic fatty liver disease (NAFLD) is a global metabolism-associated liver disease. Mesencephalic astrocyte-derived neurotrophic factor (MANF) is a newly discovered secreted protein that is involved in metabolic homeostasis. However, much remains to be discovered about its function in hepatic lipid metabolism; thus, we assessed whether MANF could regulate hepatic metabolism.AIM:To establish in vivo and in vitro NAFLD models to explore the role of MANF in hepatic lipid metabolism.METHODS:HepG2 cells treated with free fatty acids (FFAs) and ob/ob mice were used as NAFLD models. Liver tissues collected from wild type and ob/ob mice were used to detect MANF expression. Cells were treated with FFAs for different durations. Moreover, we used lentiviral constructs to establish overexpression and knockdown cell models in order to interfere with MANF expression levels and observe whether MANF influences hepatic steatosis. Western blot analysis and quantitative real-time PCR were used to detect protein and gene expression, and oil red O staining was used to visualize intracellular lipid droplets.RESULTS:Hepatic MANF protein and mRNA expression in wild type mice were 10-fold and 2-fold higher, respectively, than those in ob/ob mice. The MANF protein was temporarily increased by 1.3-fold after stimulation with FFAs for 24 h and gradually decreased to 0.66-fold that of the control at the 72 h time point in HepG2 cells. MANF deficiency upregulated the expression of genes involved in fatty acid synthesis, cholesterol synthesis, and fatty acid uptake and aggravated HepG2 cell steatosis, while MANF overexpression inhibited fatty acid synthesis and uptake and cholesterol synthesis, and rescued HepG2 cells from FFAs-induced steatosis. Furthermore, a significant decrease in triglyceride levels was observed in the MANF overexpression group compared with the control group (0.4288 ± 0.0081 mmol/g vs 0.3746 ± 0.0121 mmol/g, P < 0.05) upon FFAs treatment. There was also a 17% decrease in intracellular total cholesterol levels between the MANF overexpression group and the control group (0.1301 ± 0.0059 mmol/g vs 0.1088 ± 0.0009 mmol/g, P < 0.05) upon FFAs treatment. Moreover, MANF suppressed lipid deposition in HepG2 cells.CONCLUSION:Our findings indicate that MANF improves the phenotype of liver cell steatosis and may be a potential therapeutic target in hepatic steatosis processes.

Mesencephalic Astrocyte-Derived Neurotrophic Factor (MANF) Is Highly Expressed in Mouse Tissues With Metabolic Function

Deficiency of mesencephalic astrocyte-derived neurotrophic factor affects neurogenesis in mouse brain

MNK1 and MNK2 Mediate Adverse Effects of High-Fat Feeding in Distinct Ways

Mesencephalic astrocyte-derived neurotrophic factor (MANF): Structure, functions and therapeutic potential

Neurotrophic factor MANF regulates autophagy and lysosome function to promote proteostasis in

Loss of MANF Causes Childhood-Onset Syndromic Diabetes Due to Increased Endoplasmic Reticulum Stress

MANF: an Emerging Therapeutic Target for Metabolic Diseases

Neurotrophic factor MANF regulates autophagy and lysosome function to promote proteostasis in C. elegans

MANF Regulates Hypothalamic Control of Food Intake and Body Weight

MANF protects human pancreatic beta cells against stress-induced cell death

Mesencephalic Astrocyte-Derived Neurotrophic Factor and Its Role in Nervous System Disease

MANF in POMC Neurons Promotes Brown Adipose Tissue Thermogenesis and Protects Against Diet-Induced Obesity

The neurotrophic factor MANF regulates autophagy and lysosome function to promote proteostasis in Caenorhabditis elegans

MANF regulates metabolic and immune homeostasis in ageing and protects against liver damage

Increased Expression of Mesencephalic Astrocyte-Derived Neurotrophic Factor (MANF) Contributes to Synapse Loss in Alzheimer’s Disease

Expression and Distribution of Mesencephalic Astrocyte-Derived Neurotrophic Factor in the Retina and Optic Nerve

Circulating Mesencephalic Astrocyte-Derived Neurotrophic Factor is Increased in Newly Diagnosed Prediabetic and Diabetic Patients, and is Associated with Insulin Resistance

Mesencephalic Astrocyte-Derived Neurotrophic Factor Ameliorates Steatosis in HepG2 Cells by Regulating Hepatic Lipid Metabolism

MANF: A New Player in the Control of Energy Homeostasis, and Beyond

Mesencephalic astrocyte-derived neurotrophic factor is an ER-resident chaperone that protects against reductive stress in the heart

Deletion of mesencephalic astrocyte-derived neurotrophic factor delays and damages the development of white pulp in spleen